Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/17/24 21:35 | 5/15/24 | NTRA | Health | Health | Medical Laboratories | Chapman Steven Leonard | TX | DO | CEO,P | 7 | S.dm | -14,975 | 90.02 | 0 | -166 | 298 | D | |||||||||||||||
5/10/24 21:35 | 5/10/24 | NTRA | Health | Health | Medical Laboratories | Rabinowitz Daniel | TX | O | SEC.,GC | 6 | S.dm | -8,044 | 88.81 | 0 | -91 | 206 | D | |||||||||||||||
5/10/24 21:35 | 5/10/24 | NTRA | Health | Health | Medical Laboratories | Sheena Jonathan | TX | DH | CO-FOUND | 6 | S.dm | -4,910 | 91.15 | 0 | -54 | 494 | D | |||||||||||||||
5/3/24 21:35 | 5/1/24 | NTRA | Health | Health | Medical Laboratories | Brophy Michael Burkes | TX | O | CFO | 7 | S.dm | -1,109 | 91.38 | 0 | -12 | 73 | D | |||||||||||||||
5/1/24 21:05 | 4/29/24 | NTRA | Health | Health | Medical Laboratories | Fesko John | TX | O | P,CHIEF | 4 | S | -339 | 90.22 | 0 | -4 | 113 | D | |||||||||||||||
5/1/24 21:05 | 4/29/24 | NTRA | Health | Health | Medical Laboratories | Moshkevich Solomon | TX | O | P,CLINIC | 5 | S | -7,688 | 90.79 | 0 | -85 | 198 | D | |||||||||||||||
3/7/24 21:40 | 3/5/24 | NTRA | Health | Health | Medical Laboratories | Rabinowitz Matthew | TX | DO | Exec CB | 1 | S | -16,694 | 87.40 | 0 | -191 | 1,936 | M |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |